"As DEA rescheduling cases merge and federal hemp litigation moves to the D.C. Circuit, MMJ argues that companies following FDA rules should not be disadvantaged while non-FDA-approved cannabinoid ...

Announced April 22, 2026, and effective April 28, 2026, the Justice Department (Attorney General) and the Drug Enforcement ...

A biopharmaceutical company involved in developing drugs derived from cannabinoids, as well as several doctors and groups ...

The move only shifted a certain category of weed.

Three Republican attorneys general are asking a federal appeals court to block the Trump administration's push to reschedule ...

Alexander Malyshev and Sarah Ganley of Carter Ledyard & Milburn LLP explain the approach and significance of the final order rescheduling cannabis from Schedule I to Schedule III of the Controlled ...

Three state attorneys general are asking a federal judge to roll back medical marijuana rescheduling, despite two having MMJ programs.

The governing body of the Alabama Department of Public Health (ADPH) Thursday voted to object to a federal rescheduling of marijuana after state health officials said they needed more time to ...

"MMJ Argues Federal Government Cannot Reward State Marijuana Operators While Federally Compliant Pharmaceutical Developers Remain Trapped in Regulatory Limbo" stated Duane Boise CEO MMJ International ...

For years, the Drug Enforcement Administration has classified marijuana as a Schedule I substance, alongside many harmful drugs, including heroin, ecstasy, and LSD. Recently, U.S. President Donald ...